insights_auto
Why is JNJ down 2.30%?
Dive Deeperchevron_right
JNJ:NYSE
Johnson & Johnson
$258.66
arrow_downward
-2.30%(-6.08) 1D
$259.25
arrow_upward
+0.23% (+0.59)bedtimeAfter hours
Closed: Oct 1, 4:00:10 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for JNJ...
Open
$263.68
High
$263.98
Low
$258.33
Mkt. cap
623.34B
Avg. vol.
6.37M
Volume
8.29M
Dividend
2.07%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
29.99
52-wk high
$281.07
52-wk low
$182.94
EPS
$8.62
Beta
0.24
Shares outstanding
2.41B
No. of employees
138K
Open
$263.68
High
$263.98
Low
$258.33
Mkt. cap
623.34B
Avg. vol.
6.37M
Volume
8.29M
Dividend
2.07%
Quarterly dividend
$1.34
Ex-dividend date
Aug 25, 2026
P/E ratio
29.99
52-wk high
$281.07
52-wk low
$182.94
EPS
$8.62
Beta
0.24
Shares outstanding
2.41B
No. of employees
138K
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
BofA thinks Wall Street is underestimating one J&J drug
The Motley Fool
·
5 hours ago
Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?
News Corp
·
12 hours ago
Focused Funds Can Help You Navigate a Top-Heavy Market
Kalkine Media
·
13 hours ago
Why Is Johnson & Johnson (NYSE:JNJ) Suddenly a Must-Watch Healthcare Stocks Stock Today?
About Johnson & Johnson
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com
Analyst ratings
Based on 18 analysts giving stock ratings to JNJ in the past 3 months
Strong buy
Buy
14
Hold
4
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for JNJ in the last 3 months.
Highest
Current $258.66
$320.00 (+23.71%)
Average
$288.28 (+11.45%)
Lowest
$260.00 (+0.52%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Chris Schott J.P. Morgan | Hold | Maintained | $285.00 | +10.2% | 09/29/2026 |
Jason Gerberry Bank of America Securities | Hold | Reiterated | $278.00 | +7.5% | 09/29/2026 |
Louise Chen Scotiabank | Buy | Maintained | $305.00 | +17.9% | 09/28/2026 |
Michael Yee UBS | Buy | Maintained | $320.00 | +23.7% | 09/21/2026 |
Trung Huynh RBC Capital | Buy | Maintained | $287.00 | +11% | 09/21/2026 |
Michael Nedelcovych TD Cowen | Buy | Maintained | $300.00 | +16% | 09/14/2026 |
Nico Chen DBS | Hold | Maintained | $270.00 | +4.4% | 09/11/2026 |
Morten Herholdt HSBC | Buy | Maintained | $320.00 | +23.7% | 09/10/2026 |
Leonid Timashev RBC Capital | Buy | Maintained | $287.00 | +11% | 09/09/2026 |
Asad Haider Goldman Sachs | Buy | Maintained | $282.00 | +9% | 08/25/2026 |
Joanne Wuensch Citi | Buy | Maintained | $298.00 | +15.2% | 08/13/2026 |
Vamil Divan Guggenheim | Buy | Reiterated | $287.00 | +11% | 08/05/2026 |
Terence Flynn Morgan Stanley | Buy | Maintained | $294.00 | +13.7% | 08/03/2026 |
Larry Biegelsen Wells Fargo | Buy | Maintained | $282.00 | +9% | 08/03/2026 |
David Toung Argus Research | Buy | Reiterated | $300.00 | +16% | 07/28/2026 |
David Risinger Leerink Partners | Buy | Maintained | $276.00 | +6.7% | 07/17/2026 |
Ilya Zubkov Freedom Capital Markets | Buy | Upgraded | $280.00 | +8.3% | 07/16/2026 |
Jayson Bedford Raymond James | Buy | Maintained | $265.00 | +2.5% | 07/16/2026 |
Rick Wise Stifel Nicolaus | Hold | Maintained | $260.00 | +0.5% | 07/15/2026 |
Shagun Singh Chadha RBC Capital | Buy | Maintained | $287.00 | +11% | 07/13/2026 |
Steve Scala TD Cowen | Buy | Maintained | $300.00 | +16% | 07/13/2026 |
Matt Miksic Barclays | Hold | Reiterated | $255.00 | -1.4% | 05/13/2026 |
Hans Engel Erste Group | Buy | Maintained | - | - | 05/05/2026 |
Josh Jennings TD Cowen | Buy | Maintained | $250.00 | -3.3% | 04/23/2026 |
Lee Hambright Bernstein | Hold | Maintained | - | - | 04/14/2026 |
Danielle Antalffy UBS | Buy | Reiterated | $280.00 | +8.3% | 03/17/2026 |
Next call in 11 days
Tue, Oct 13, 2:30 PM
Fiscal period
Q3 2026
EPS / Est. (USD)
- / $2.48
Revenue / Est. (USD)
- / 25.31B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 23.99B | 24.56B | 24.06B | 25.31B |
Cost of goods sold | 7.29B | 7.81B | 8.09B | 8.02B |
Cost of revenue | 7.29B | 7.81B | 8.09B | 8.02B |
Research and development expenses | 3.67B | 4.25B | 3.53B | 3.65B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 5.78B | 6.61B | 5.85B | 6.25B |
Operating expense | 9.46B | 10.86B | 9.38B | 9.91B |
Total operating expenses | 16.75B | 18.68B | 17.47B | 17.92B |
Operating income | 7.25B | 5.89B | 6.60B | 7.39B |
Other non operating income | 17.00M | 396.00M | -211.00M | 110.00M |
EBT including unusual items | 7.49B | 4.97B | 5.99B | 6.75B |
EBT excluding unusual items | 7.27B | 6.03B | 6.41B | 7.42B |
Income tax expense | 2.34B | -150.00M | 755.00M | 1.21B |
Effective tax rate | 31.24% | -3.02% | 12.60% | 17.98% |
Other operating expenses | - | - | - | - |
Net income | 5.15B | 5.12B | 5.24B | 5.53B |
Net profit margin | 21.47% | 20.83% | 21.76% | 21.86% |
Earnings per share | 2.80 | 2.46 | 2.70 | 2.90 |
Interest and investment income | 227.00M | 237.00M | 229.00M | 219.00M |
Interest expense | -245.00M | -214.00M | -272.00M | -281.00M |
Net interest expenses | -18.00M | 23.00M | -43.00M | -62.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 9.02B | 7.90B | 8.60B | 9.35B |
Gain or loss from assets sale | -57.00M | -132.00M | 12.00M | -55.00M |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1